The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV
Abstract
Since the 1970s, mortality in the hemophilia population has been dominated by human immunodeficiency virus (HIV) and few reports have described mortality in uninfected individuals. This study presents mortality in 6018 people with hemophilia A or B in the United Kingdom during 1977 to 1998 who were not infected with HIV, with follow-up until January 1, 2000. Given disease severity and factor inhibitor status, all-cause mortality did not differ significantly between hemophilia A and hemophilia B. In severe hemophilia, all-cause mortality did not change significantly during 1977 to 1999. During this period, it exceeded mortality in the general population by a factor of 2.69 (95% confidence interval [CI]: 2.37-3.05), and median life expectancy in severe hemophilia was 63 years. In moderate/mild hemophilia, all-cause mortality did not change significantly during 1985 to 1999, and median life expectancy was 75 years. Compared with mortality in the general population, mortality from bleeding and its consequences, and from liver diseases and Hodgkin disease, was increased, but for ischemic heart disease it was lower, at only 62% (95% CI: 51%-76%) of general population rates, and for 14 other specific causes it did not differ significantly from general population rates. There was no evidence of any death from variant Creutzfeldt-Jakob disease or from conditions that could be confused with it.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bolton-Maggs, P. H., & Pasi, K. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13405-8 · Cited by 763
Darby, S. C., Keeling, D. M., Spooner, R. J. D., Wan Kan, S., Giangrande, P. L. F., Collins, P. W., Hill, F. G. H., & Hay, C. R. M. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2004.00710.x · Cited by 270
Self-citationMortality and causes of death in Dutch haemophiliacs, 1973–86
Rosendaal, F. R., Varekamp, I., Smit, C., Bröcker‐Vriends, A. H. J. T., Van Dijck, H., Vandenbroucke, J. P., Hermans, J., Suurmeijer, T. P. B. M., & Briët, E. (1989) · British Journal of Haematology · doi:10.1111/j.1365-2141.1989.tb06277.x · Cited by 205
B‐cell non‐Hodgkin's lymphoma and hepatitis C virus infection: A systematic review
Negri, E., Little, D., Boiocchi, M., La Vecchia, C., & Franceschi, S. (2004) · International Journal of Cancer · doi:10.1002/ijc.20205 · Cited by 158
Life expectancy of Swedish haemophiliacs, 1831–1980
Larsson, S. A. (1985) · British Journal of Haematology · doi:10.1111/j.1365-2141.1985.tb07353.x · Cited by 155
Haemophilia protects against ischaemic heart disease: a study of risk factors
Rosendaal, F. R., Briët, E., Stibbe, J., van Herpen, G., Leuven, J. A. G., Albert Hofman, D., & Vandenbroucke, J. P. (1990) · British Journal of Haematology · doi:10.1111/j.1365-2141.1990.tb07793.x · Cited by 146
Rizza, C. R., & Spooner, R. J. D. (1983) · BMJ · doi:10.1136/bmj.286.6369.929 · Cited by 136
Self-citationMortality before and after HIV infection in the complete UK population of haemophiliacs
Darby, S. C., Ewart, D. W., Giangrande, P. L. F., Dolin, P., Spooner, R. J. D., & Rizza, C. R. (1995) · Nature · doi:10.1038/377079a0 · Cited by 127
Self-citationDecreased mortality of ischaemic heart disease among carriers of haemophilia
Šrámek, A., Kriek, M., & Rosendaal, F. R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14021-4 · Cited by 124
Prevalence and risk factors for heart disease among males with hemophilia
Kulkarni, R., Soucie, J. M., Evatt, B. L., & and the Hemophilia Surveillance System Project Investigators (2005) · American Journal of Hematology · doi:10.1002/ajh.20339 · Cited by 120
Cited by
Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
Nathwani, A. C., Tuddenham, E. G. D., Rangarajan, S., Rosales, C., McIntosh, J., Linch, D. C., Chowdary, P., Riddell, A., Pie, A. J., Harrington, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108046 · Cited by 1,864
AAV5–Factor VIII Gene Transfer in Severe Hemophilia A
Rangarajan, S., Walsh, L., Lester, W., Perry, D., Madan, B., Laffan, M., Yu, H., Vettermann, C., Pierce, G. F., Wong, W. Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708483 · Cited by 694
Iorio, A., Stonebraker, J. S., Chambost, H., Makris, M., Coffin, D., Herr, C., Germini, F., & for the Data and Demographics Committee of the World Federation of Hemophilia* (2019) · Annals of Internal Medicine · doi:10.7326/m19-1208 · Cited by 462
A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)
GRINGERI, A., LUNDIN, B., VON MACKENSEN, S., MANTOVANI, L., & MANNUCCI, P. M. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04214.x · Cited by 454
Berntorp, E., & Shapiro, A. D. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61139-2 · Cited by 335
Metadata
- Authors
- Darby, S. C., Kan, S. W., Spooner, R. J., Giangrande, P. L. F., Hill, F. G. H., Hay, C. R. M., Lee, C. A., Ludlam, C. A., & Williams, M.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2007-08-01
- Volume
- 110
- Issue
- 3
- Pages
- 815-825
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2095331703
- Cited by
- 511
- References
- 18
- FWCI
- 11.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. https://app.cochat.ai/papers/10.1182/blood-2006-10-050435
- The paper
- Darby, S. C., Kan, S. W., Spooner, R. J., Giangrande, P. L. F., Hill, F. G. H., Hay, C. R. M., Lee, C. A., Ludlam, C. A., & Williams, M. (2007). Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood. https://doi.org/10.1182/blood-2006-10-050435
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.